Did Marjorie Greene buy CRISPR Therapeutics stock?

Common questions

Did Marjorie Greene buy CRISPR Therapeutics stock?

Yes. Marjorie Greene disclosed 1 purchase of CRISPR Therapeutics (CRSP) stock on Jan 21, 2021, in STOCK Act reports. Added together, the disclosed ranges come to $1K-$15K.

How big were Marjorie Greene's CRISPR Therapeutics trades?

STOCK Act reports give a range for each trade, such as $1K-$15K, never an exact amount. Added together, the disclosed ranges come to $1K-$15K.

Did Marjorie Greene make these CRISPR Therapeutics trades personally?

Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.

Does Marjorie Greene still own CRISPR Therapeutics stock?

This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.

When did Marjorie Greene report these trades?

The latest filing is dated Feb 19, 2021. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.

Where does this data come from?

From periodic transaction reports filed under the STOCK Act with the Clerk of the House. Every trade links to the original filing.